Semi-Mechanism-Based Pharmacokinetic-Toxicodynamic Model of Oxaliplatin-Induced Acute and Chronic Neuropathy
Oxaliplatin (L-OHP) is widely prescribed for treating gastroenterological cancer. L-OHP-induced peripheral neuropathy is a critical toxic effect that limits the dosage of L-OHP. An ideal chemotherapeutic strategy that does not result in severe peripheral neuropathy but confers high anticancer effica...
Saved in:
Main Authors: | Shinji Kobuchi (Author), Risa Shimizu (Author), Yukako Ito (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2020-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmacokinetic and Toxicodynamic Characterization of a Novel Doxorubicin Derivative
by: Samaa Alrushaid, et al.
Published: (2017) -
Donepezil ameliorates oxaliplatin-induced peripheral neuropathy via a neuroprotective effect
by: Takehiro Kawashiri, et al.
Published: (2019) -
Pharmacokinetics of Macrolide Antibiotics and Transport into the Interstitial Fluid: Comparison among Erythromycin, Clarithromycin, and Azithromycin
by: Shinji Kobuchi, et al.
Published: (2020) -
Multimodal assessment of painful peripheral neuropathy induced by chronic oxaliplatin-based chemotherapy in mice
by: Dorsey Susan G, et al.
Published: (2011) -
Oxaliplatin-Induced Peripheral Neuropathy Grade in Females with Colorectal Cancer Patients
by: Inas Moawya Ahmed, et al.
Published: (2019)